CC
SWTX

CIBRA Capital’s SpringWorks Therapeutics SWTX Stock Holding History

CIBRA Capital’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$1.66M Buy
+37,543
New +$1.73M 0.57% 19

Other funds holding SWTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

CIBRA Capital's SWTX Position: Q1 2025 in Review

CIBRA Capital opened a new position in SpringWorks Therapeutics (SWTX) in Q1 2025: 37,543 shares worth $1.66M. The stake represents 0.57% of the portfolio and ranks #19 among its holdings.

306 funds tracked by Wall St. Rank hold SWTX as of Q1 2025.

  • CIBRA Capital held 37,543 shares of SpringWorks Therapeutics worth $1.66M as of Q1 2025.
  • SpringWorks Therapeutics was a new CIBRA Capital position in Q1 2025.
  • SpringWorks Therapeutics made up 0.57% of CIBRA Capital's portfolio in Q1 2025, its #19 holding.
  • 306 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q1 2025.

Based on CIBRA Capital's 13F filing for Q1 2025, filed 28 Apr 2025.